Skip to main content

Peer Review reports

From: CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1

Original Submission
27 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Aug 2022 Reviewed Reviewer Report - Hsiang-lin Lee
27 Sep 2022 Reviewed Reviewer Report
4 Oct 2022 Author responded Author comments - Yan Ma
Resubmission - Version 4
4 Oct 2022 Submitted Manuscript version 4
11 Oct 2022 Author responded Author comments - Yan Ma
Resubmission - Version 5
11 Oct 2022 Submitted Manuscript version 5
13 Oct 2022 Author responded Author comments - Yan Ma
Resubmission - Version 6
13 Oct 2022 Submitted Manuscript version 6
26 Oct 2022 Reviewed Reviewer Report - Hsiang-lin Lee
9 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
15 Nov 2022 Editorially accepted
22 Nov 2022 Article published 10.1186/s12885-022-10318-8

You can find further information about peer review here.

Back to article page